Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: PACLITAXEL, . Treffer: 89

2023

Shishehbor, MH; Scheinert, D; Jain, A; Brodmann, M; Tepe, G; Ando, K; Krishnan, P; Iida, O; Laird, JR; Schneider, PA; Rocha-Singh, KJ; Zeller, T Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease
J AM COLL CARDIOL. 2023; 81(3): 237-249. Doi: 10.1016/j.jacc.2022.10.016
Web of Science PubMed FullText FullText_MUG

 

2022

Deloose, K; Lansink, W; Brodmann, M; Werner, M; Keirse, K; Goueffic, Y; Verbist, J; Maene, L; Hendriks, J; Brunet, J; Ducasse, E; Levent, K; Sauguet, A; Deglise, S; Vandael, F Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery
CARDIOVASC INTER RAD. 2022; Doi: 10.1007/s00270-022-03259-z
Web of Science PubMed FullText FullText_MUG

 

Linn, YL; Wang, JCC; Pua, U; Yahaya, SAB; Choke, ETC; Chong, TT; Brodmann, M; Tang, TY Utility of paclitaxel-coated balloons for the treatment of infrainguinal disease in the Asian population-24-month outcome data from the BIOLUX P-III Global Registry 24-month Asian outcomes of BIOLUX P-III
VASCULAR. 2022; 17085381221081969 Doi: 10.1177/17085381221081969
Web of Science PubMed FullText FullText_MUG

 

Lyden, SP; Brodmann, M; Parikh, SA; Krishnan, P; Schroeder, H; Werner, M; Holden, A; Ouriel, K; Tarra, T; Gray, WA Four-year patient-level pooled mortality analysis of the ILLUMENATE US Pivotal and EU randomized controlled trials.
J Vasc Surg. 2022; 75(2): 600-607. Doi: 10.1016/j.jvs.2021.07.244
Web of Science PubMed FullText FullText_MUG

 

Lyden, SP; Faries, PL; Niazi, KAK; Sachar, R; Jain, A; Brodmann, M; Werner, M; Sood, A; Krishnan, P No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.
J Endovasc Ther. 2022; 15266028211068769 Doi: 10.1177/15266028211068769
Web of Science PubMed FullText FullText_MUG

 

Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

Schroe, H; Sachar, R; Keirse, K; Soga, Y; Brodmann, M; Rao, V; Werner, M; Holden, A; Lopez, L; Krishnan, P; Diaz-Cartelle, J The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort
VASC MED. 2022; Doi: 10.1177/1358863X221097164 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Shishehbor, MH; Zeller, T; Werner, M; Brodmann, M; Parise, H; Holden, A; Lichtenberg, M; Parikh, SA; Kashyap, VS; Pietras, C; Tirziu, D; Ardakani, S; Beschorner, U; Krishnan, P; Niazi, KA; Wali, AU; Lansky, AJ Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study)
CIRCULATION. 2022; 145(22): 1645-1654. Doi: 10.1161/CIRCULATIONAHA.122.059646
Web of Science PubMed FullText FullText_MUG

 

2021

El, Khoury, R; Brodmann, M; Schneider, PA Progress on developing an effective below-the-knee drug-coated balloon.
REV CARDIOVASC MED. 2021; 22(3): 585-595. Doi: 10.31083/j.rcm2203070 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ghafouri-Fard, S; Shoorei, H; Abak, A; Abbas Raza, SH; Pichler, M; Taheri, M Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.
Biomed Pharmacother. 2020; 134: 111172-111172. Doi: 10.1016/j.biopha.2020.111172 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13: 17588359211039930 Doi: 10.1177/17588359211039930 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pichler, M; Steyrer, J Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1.
ESMO Open. 2021; 6(4): 100198 Doi: 10.1016/j.esmoop.2021.100198 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pink, D; Andreou, D; Bauer, S; Brodowicz, T; Kasper, B; Reichardt, P; Richter, S; Lindner, LH; Szkandera, J; Gruenwald, V; Kebenko, M; Kirchner, M; Hohenberger, P Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(R) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
CANCERS. 2021; 13(6): 1223 Doi: 10.3390/cancers13061223 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Prager, GW; Oehler, L; Gerger, A; Mlineritsch, B; Andel, J; Petzer, A; Wilthoner, K; Sliwa, T; Pichler, P; Winder, T; Heibl, S; Gruenberger, B; Laengle, F; Hubmann, E; Korger, M; Pecherstorfer, M; Djanani, A; Neumann, HJ; Philipp-Abbrederis, K; Wöll, E; Trondl, R; Arnold-Schrauf, C; Eisterer, W Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer. 2021; 143:101-112 Doi: 10.1016/j.ejca.2020.11.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sachar, R; Soga, Y; Ansari, MM; Kozuki, A; Lopez, L; Brodmann, M; Schroë, H; Ramanath, VS; Diaz-Cartelle, J; Zeller, T, , RANGER, II, SFA, Investigators 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon.
JACC-CARDIOVASC INTE. 2021; 14(10): 1123-1133. Doi: 10.1016/j.jcin.2021.03.021
Web of Science PubMed FullText FullText_MUG

 

Tepe, G; Wang, J; Corpataux, JM; Pua, U; Binkert, CA; Moscovic, M; Ghotbi, R; Keirse, K; Robertson, D; Brodmann, M BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries.
Cardiovasc Intervent Radiol. 2021; 44(1):10-18 Doi: 10.1007/s00270-020-02586-3
Web of Science PubMed FullText FullText_MUG

 

Tepe, G; Zeller, T; Moscovic, M; Corpataux, JM; Christensen, JK; Keirse, K; Nano, G; Schroeder, H; Binkert, CA; Brodmann, M Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry.
Cardiovasc Intervent Radiol. 2021; 44(2):207-217 Doi: 10.1007/s00270-020-02663-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Brodmann, M; Moscovic, M; Wang, JCC; Nano, G; Dahm, J; Zeller, T; Christensen, JK; Keirse, K; Ghotbi, R; Corpataux, JM; Tepe, G Real-World Experience With a Paclitaxel-Coated Balloon in Critical Limb Ischemia: 24-Month Subgroup Outcomes of BIOLUX P-III.
JACC Cardiovasc Interv. 2020; 13(19):2289-2299 Doi: 10.1016/j.jcin.2020.06.059 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Harter, P; Pautier, P; Van Nieuwenhuysen, E; Reuss, A; Redondo, A; Lindemann, K; Kurzeder, C; Petru, E; Heitz, F; Sehouli, J; Degregorio, N; Wimberger, P; Burges, A; Cron, N; Ledermann, J; Lorusso, D; Paoletti, X; Marme, F Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
Int J Gynecol Cancer. 2020; 30(12): 1997-2001. Doi: 10.1136/ijgc-2020-001572
Web of Science PubMed FullText FullText_MUG

 

Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Wöll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol. 2020; 12: 1758835919900872-1758835919900872. Doi: 10.1177/1758835919900872 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, PA; Brodmann, M; Mauri, L; Laird, J; Soga, Y; Micari, A; Ansel, G; Shishehbor, MH; Krishnan, P; Gao, Q; Ouriel, K; Zeller, T Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials.
Catheter Cardiovasc Interv. 2020; 96(5):1087-1099 Doi: 10.1002/ccd.29152 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tepe, G; Zeller, T; Moscovic, M; Corpataux, JM; Christensen, JK; Keirse, K; Nano, G; Schroeder, H; Binkert, CA; Brodmann, M Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry.
J Endovasc Ther. 2020; 27(2):304-315 Doi: 10.1177/1526602819898804 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zeller, T; Micari, A; Scheinert, D; Baumgartner, I; Bosiers, M; Vermassen, FEG; Banyai, M; Shishehbor, MH; Wang, H; Brodmann, M; IN.PACT DEEP Trial Investigators The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
JACC Cardiovasc Interv. 2020; 13(4):431-443 Doi: 10.1016/j.jcin.2019.10.059 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Elmariah, S; Ansel, GM; Brodmann, M; Doros, G; Fuller, S; Gray, WA; Pinto, DS; Rosenfield, KA; Mauri, L Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.
AM HEART J. 2019; 209(4): 88-96. Doi: 10.1016/j.ahj.2018.12.012
Web of Science PubMed FullText FullText_MUG

 

Garofalo, M; Villa, A; Rizzi, N; Kuryk, L; Rinner, B; Cerullo, V; Yliperttula, M; Mazzaferro, V; Ciana, P Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice.
J CONTROL RELEASE. 2019; 294(12): 165-175. Doi: 10.1016/j.jconrel.2018.12.022 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gray, WA; Jaff, MR; Parikh, SA; Ansel, GM; Brodmann, M; Krishnan, P; Razavi, MK; Vermassen, F; Zeller, T; White, R; Ouriel, K; Adelman, MA; Lyden, SP Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years.
Circulation. 2019; 140(14):1145-1155 Doi: 10.1161/CIRCULATIONAHA.119.040518 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koch, OO; Weitzendorfer, M; Varga, M; Tschoner, A; Partl, R; Perathoner, A; Gehwolf, P; Kapp, KS; Függer, R; Öfner, D; Emmanuel, K Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis.
World J Surg Oncol. 2019; 17(1): 146-146. Doi: 10.1186/s12957-019-1693-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Laird, JA; Schneider, PA; Jaff, MR; Brodmann, M; Zeller, T; Metzger, DC; Krishnan, P; Scheinert, D; Micari, A; Wang, H; Masters, M; Tepe, G Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
CIRC-CARDIOVASC INTE. 2019; 12(6): e007702-e007702. Doi: 10.1161/CIRCINTERVENTIONS.118.007702 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lorusso, D; Hilpert, F; González Martin, A; Rau, J; Ottevanger, P; Greimel, E; Lück, HJ; Selle, F; Colombo, N; Kroep, JR; Mirza, MR; Berger, R; Pardo, B; Grischke, EM; Berton-Rigaud, D; Martinez-Garcia, J; Vergote, I; Redondo, A; Cardona, A; Bastière-Truchot, L; du Bois, A; Kurzeder, C; PENELOPE trial investigators Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer.
INT J GYNECOL CANCER. 2019; 29(7): 1141-1147. Doi: 10.1136/ijgc-2019-000370
Web of Science PubMed FullText FullText_MUG

 

Mustapha, JA; Brodmann, M; Geraghty, PJ; Saab, F; Settlage, RA; Jaff, MR; Lutonix BTK Study Investigators Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial.
J Invasive Cardiol. 2019; 31(8):205-211 [OPEN ACCESS]
Web of Science PubMed

 

Ouriel, K; Adelman, MA; Rosenfield, K; Scheinert, D; Brodmann, M; Peña, C; Geraghty, P; Lee, A; White, R; Clair, DG Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
JACC Cardiovasc Interv. 2019; 12(24):2515-2524 Doi: 10.1016/j.jcin.2019.08.025 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scheithauer, W; Putora, PM; Grünberger, B; Eisterer, W; Wöll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Therap Adv Gastroenterol. 2019; 12(5):1756284819877635-1756284819877635 Doi: 10.1177/1756284819877635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, PA; Laird, JR; Doros, G; Gao, Q; Ansel, G; Brodmann, M; Micari, A; Shishehbor, MH; Tepe, G; Zeller, T Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
J Am Coll Cardiol. 2019; 73(20):2550-2563 Doi: 10.1016/j.jacc.2019.01.013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zeller, T; Brodmann, M; Micari, A; Keirse, K; Peeters, P; Tepe, G; Scheinert, D; Jaff, MR; Rocha-Singh, KJ; Li, P; Schmahl, R; Ansel, GM; IN.PACT Global Study Investigators Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain.
Circ Cardiovasc Interv. 2019; 12(1):e007730-e007730 Doi: 10.1161/CIRCINTERVENTIONS.118.007730 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Brodmann, M; Zeller, T; Christensen, J; Binkert, C; Spak, L; Schröder, H; Righini, P; Nano, G; Tepe, G Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment.
J Vasc Bras. 2018; 16(4): 276-284. Doi: 10.1590/1677-5449.007317 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Ma, YT; Yang, Y; Cai, P; Sun, DY; Sánchez-Murcia, PA; Zhang, XY; Jia, WQ; Lei, L; Guo, M; Gago, F; Wang, H; Fang, WS A Series of Enthalpically Optimized Docetaxel Analogues Exhibiting Enhanced Antitumor Activity and Water Solubility.
J Nat Prod. 2018; 81(3):524-533 Doi: 10.1021/acs.jnatprod.7b00857
Web of Science PubMed FullText FullText_MUG

 

Micari, A; Brodmann, M; Keirse, K; Peeters, P; Tepe, G; Frost, M; Wang, H; Zeller, T; IN.PACT Global Study Investigators Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
JACC-CARDIOVASC INTE. 2018; 11(10): 945-953. Doi: 10.1016/j.jcin.2018.02.019 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scheinert, D; Micari, A; Brodmann, M; Tepe, G; Peeters, P; Jaff, MR; Wang, H; Schmahl, R; Zeller, T; IN.PACT Global Study Investigators Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease.
CIRC-CARDIOVASC INTE. 2018; 11(10): e005654-e005654. Doi: 10.1161/CIRCINTERVENTIONS.117.005654 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, PA; Laird, JR; Tepe, G; Brodmann, M; Zeller, T; Scheinert, D; Metzger, C; Micari, A; Sachar, R; Jaff, MR; Wang, H; Hasenbank, MS; Krishnan, P; IN.PACT SFA Trial Investigators Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
CIRC-CARDIOVASC INTE. 2018; 11(1): e005891-e005891. Doi: 10.1161/CIRCINTERVENTIONS.117.005891 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Thieme, M; Lichtenberg, M; Brodmann, M; Cioppa, A; Scheinert, D Lutonix® 014 DCB global Below the Knee Registry Study: interim 6-month outcomes.
J CARDIOVASC SURG. 2018; 59(2): 232-236. Doi: 10.23736/S0021-9509.18.10269-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Brodmann, M; Keirse, K; Scheinert, D; Spak, L; Jaff, MR; Schmahl, R; Li, P; Zeller, T; IN.PACT Global Study Investigators Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
JACC-CARDIOVASC INTE. 2017; 10(20): 2113-2123. Doi: 10.1016/j.jcin.2017.06.018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dinkic, C; Jahn, F; Zygmunt, M; Schuetz, F; Rom, J; Sohn, C; Fluhr, H PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis
ONCOL LETT. 2017; 13(4): 2847-2851. Doi: 10.3892/ol.2017.5795
Web of Science PubMed FullText FullText_MUG

 

Dinkic, C; Kruse, A; Zygmunt, M; Schuetz, F; Brucker, J; Rom, J; Sohn, C; Fluhr, H Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
GEBURTSH FRAUENHEILK. 2017; 77(10): 1104-1110. Doi: 10.1055/s-0043-119289
Web of Science PubMed FullText FullText_MUG

 

Krishnan, P; Faries, P; Niazi, K; Jain, A; Sachar, R; Bachinsky, WB; Cardenas, J; Werner, M; Brodmann, M; Mustapha, JA; Mena-Hurtado, C; Jaff, MR; Holden, AH; Lyden, SP Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
CIRCULATION. 2017; 136(12): 1102-1113. Doi: 10.1161/CIRCULATIONAHA.117.028893 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schroeder, H; Werner, M; Meyer, DR; Reimer, P; Krüger, K; Jaff, MR; Brodmann, M; ILLUMENATE EU RCT Investigators Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
CIRCULATION. 2017; 135(23): 2227-2236. Doi: 10.1161/CIRCULATIONAHA.116.026493 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Kahler, K; Stadler, R; Berking, C; Holler, C; Kerschke, L; Edler, L; Kopp-Schneider, A; Becker, JC Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
ONCOTARGET. 2017; 8(44): 76029-76043. Doi: 10.18632/oncotarget.18635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Czink, E; Heining, C; Weber, TF; Lasitschka, F; Schemmer, P; Schirmacher, P; Weiss, KH; Glimm, H; Brors, B; Weichert, W; Jäger, D; Fröhling, S; Springfeld, C [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Z Gastroenterol. 2016; 54(5):426-430 Doi: 10.1055/s-0042-103498
Web of Science PubMed FullText FullText_MUG

 

Hoeppner, J; Lordick, F; Brunner, T; Glatz, T; Bronsert, P; Röthling, N; Schmoor, C; Lorenz, D; Ell, C; Hopt, UT; Siewert, JR ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
BMC Cancer. 2016; 16:503 Doi: 10.1186/s12885-016-2564-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Prieto-Torres, L; Llamas-Velasco, M; Machan, S; Haro, R; de Asis, S; Carmo, M; Loredo, A; del Puerto, C; Fried, I; Kempf, W; Cerroni, L; Requena, L Taxanes-induced cutaneous eruption: another histopathologic mimicker of malignancy.
J Eur Acad Dermatol Venereol. 2016; 30(4):638-644 Doi: 10.1111/jdv.13475
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum